Retinal involvement in type 2 diabetics with microalbuminuria;Evaluación del compromiso retinal en diabéticos tipo 2 microalbuminúricos

Revista Medica de Chile

Volumn 128, Issue 10, 2000, Pages 1085-1092

  Durruty A , Pilar ^a   Carpentier G , Cristián ^a   Krause I , Paulina ^a   García De Los Ríos A , Manuel ^a  

^a NONE

Author keywords

Diabetes mellitus, non insulin dependent; Diabetic angiopathies; Diabetic nephropathies; Diabetic retinopathy

Indexed keywords

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ARTICLE; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCHOOL CHILD; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; RISK; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; RADIOIMMUNOASSAY; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0034303723     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ZIMMET P, MCCARTY D. The NIDDM epidemic: global estimates and projection-a look into the crystal ball. IDF Bulletin 1995; 40: 8-16.
2. KLEIN R, KLEIN BEK, MOSS SE, DAVIS MD, DEMETS DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthal 1984; 102: 527-32.
3. WIRTA OR, PASTERNACK AI, OKSA HH, MUSTONEN JT, KOIVULA TA, HELIN HJ, ET AL. Ocurrence of late complications in type 2 (non-insulin dependent) diabetes mellitus. J Diabetes Complications 1995; 9: 177-85.
4. GARCÍA DE LOS RÍOS M, VALIENTE S, CANESSA I, MELLA I, TAUCHER R. Complicaciones degenerativas y sobrevida de los diabéticos. Rev Méd Chile 1972; 100: 733-40.
5. ZAHR M, GARCÍA DE LOS RÍOS M, MELLA I, CARRASCO E. ¿Existe asociación entre retinopatĩa diabética y reacciõn Clorpropamida-alcohol-rubor? Rev Méd Chile 1983; 111: 235-40.
6. ARFKEN C, RENO P, SANTIAGO JV, KLEIN R. Development of proliferative diabetic retinopathy in African-American and whites with type 1 diabetes. Diabetes Care 1998; 21: 792-5.
7. HARRIS MI, KLEIN R, WELBORN TA, KNUIMAN MW. Onset of NIDDM occurs at least 4-7 year before clinical diagnosis. Diabetes Care 1992; 15: 815-9.
8. UNITED KINGDOM. Prospective Diabetes Study Group UKPDS 33. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-53.
9. OHKUBO Y, KISHIKAWA H, ARAKI E, MIYATA I, ISAMI S, MOTOYOSHI S, ET AL. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized, prospective 6 years study. Diabetes Res Clin Pract 1995; 28: 103-17.
10. KLEIN R, KLEIN BEK. Relation of glicemic control to diabetic complications and health outcomes. Diabetes Care 1998; 21 (Suppl 3) C 39-C43.
11. UNITED KINGDON PROSPECTIVE DIABETES STUDY GROUP. Efficacy of atenolol and captopril reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS. BMJ 1998; 317: 713-20.
12. BLOOMGARDEN ZT. American Diabetes Association Anual Meeting 1999. Nephropathy and retinopathy. Diabetes Care 1999; 22: 640-4.
13. DECKERT T, KOFOED-ENEVOLDSEN A, NORGAARD K, BORCH-JOHNSEN K, FELDT-RASMUSSEN B, JENSEN T. Microalbuminuria. Implications for micro and macrovascular disease. Diabetes Care 1992; 15: 1181-92.
14. MOGENSEN CE, CHRISTENSEN CK. Predicting diabetic nephropathy in insulin-dependent diabetic patients. N Engl J Med 1984; 311: 89-93.
15. KLEIN R, KLEIN BEK, MOSS SE. Prevalence of microalbuminuria in older onset diabetes. Diabetes Care 1993; 16: 1325-9.
16. DECKERT T, FELD-RASMUSSEN B, BORCH-JOHNSEN K, JENSEN T, KOFOED-ENEVOLDSEN A. Albuminuria reflects widespread vascular damage: The Steno hypothesis. Diabetologia 1989; 32: 219-26.
17. GALL MA, ROSSING P, SKOTT P, DAMSBO P, VAAG A, BECH K, ET AL. Prevalence of micro and macro albuminuria, arterial hypertension, retinopathy and large vessel disease in european type 2 (non-insulin-dependent) diabetic patients Diabetologia 1991; 34: 655-61.
18. LUNETTA M, INFANTONE L, CALOGERO AE, INFANTONE E. Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 1998; 40: 45-51.
19. WIRTA OR, PASTERNACK A, MUSTONEN J, LAIPPALA P, LAHDE Y. Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. Clin Nephrol 1999; 51: 329-34.
20. TAYLOR RH, JONES HS, DODSON PM, HAMILTON AP, KRITZINGER EE. Diabetic eye disease: a natural history study. Eye 1997; 11: 547-53.
21. FERRIS FL, DAVIS MD, AIELLO LM. Treatment of diabetic retinopathy. N Engl Med 1999; 341: 667-78.
22. MATHIESEN ER, RONN B, STORM B, FOGHT H, DECKERT T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10 year prospective study. Diabet Med 1995: 12: 482-7.
23. CHATURVIDE N, SJOLIE AK, STEPHENSON JM, ABRAHAMIAN H, KEIPES M, CASTELLARIN A, ET AL. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998; 351: 28-31.